ClinConnect ClinConnect Logo
Search / Trial NCT04919447

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how different ways of pacing the heart can help patients with slow heart rates (bradyarrhythmias) and heart failure. The goal is to compare the short-term and long-term effects and safety of various pacing locations in the heart, like the right atrium, right ventricle, and left bundle branch. By understanding which pacing method works best, the researchers hope to improve treatment for these conditions.

To participate in the study, you need to be between the ages of 65 and 74 or 36 and 52 years old and have received a pacemaker at the Second Hospital of Zhejiang Medical University. It’s important that you can understand the study and work with the researchers. If you join, you can expect regular follow-ups to monitor how well the pacing is working for you and to ensure your safety throughout the trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients who received pacemaker implantation in the Second Hospital of Zhejiang Medical University by Pan Xiaohong and other surgeons.
  • Patients who have the ability to understand the test and can cooperate with investigators.
  • Exclusion Criteria:
  • Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors

About Second Affiliated Hospital, School Of Medicine, Zhejiang University

The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.

Locations

Hangzhou, Zhejiang, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials